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ORIGINAL RESEARCH

Improving Communication between Doctors
and Parents after Newborn Screening
Michael H. Farrell, MD; Stephanie A. Christopher, MA; Audrey Tluczek, PhD, RN; Karen Kennedy-Parker, MT(ASCP); Alison La
Pean, MS, CGC; Kerry Eskra, BBA; Jenelle Collins, BSN, RN; Gary Hoffman, MS; Julie Panepinto, MD; Philip M. Farrell, MD, PhD
erozygous (“carrier”) status for cystic
fibrosis (CF) or sickle cell hemoglobinopathy (SCH).
ral vehicle for genetic screening. Bioethicists argue for caution since families of infants with
NBS is a population-scale pubcarrier status can develop psychosocial complications. This paper describes the methods and
lic health program in which newborn
feasibility of Wisconsin’s statewide project for quality improvement of communication and
infants’ blood specimens are applied to
psychosocial outcomes after NBS.
a special filter paper, dried, and tested
Methods: When NBS identifies carrier status for cystic fibrosis or sickle cell, we contact
at a centralized laboratory for a panel
primary care providers (PCPs), answer questions, and invite them to rehearse informing the
of genetic and metabolic diseases.1 CF
parents. Three months later, we telephone the parents, assess knowledge and psychosocial
and SCH are included on NBS panels
outcomes, provide counseling, and assist with self-referral to further resources. Afterward,
because the diseases’ risk of death and
evaluation surveys are provided to the parents, to be returned anonymously.
disability can be reduced if the disease
Results: Birthing facilities provided accurate PCP names for 73% of 817 infants meeting incluis identified before becoming symptomsion criteria; we identified PCPs for 21% more. We reached 47.3% of PCPs in time to invite
atic.2-4
a rehearsal; 60% of these accepted. We successfully called 50.2% of eligible parents; 61%
CF is a metabolic disease in which
recalled a PCP explanation, and 48.5% evaluated the explanation favorably. Evaluations by
abnormal secretions lead to lung disease,
parents with limited health literacy were less favorable.
nutritional problems, and dangerous
Conclusion: It is feasible to follow parents for psychosocial outcomes after NBS. Preliminary
losses of salt in sweat.2 SCH is a blood
data about communication is mixed, but further data will describe psychosocial outcomes
disorder in which a hemoglobin mutaand investigate outcomes’ associations with communication.
tion (S) is associated with painful crises,
life-threatening infections, and vasculopathy, leading to problems like stroke.3
Both CF and SCH are autosomal
INTRODUCTION
recessive conditions, and carrier infants are identified in far
This paper describes the methods, feasibility, and early experi- greater numbers than infants with the actual diseases. Infants
ence of a statewide, multifaceted quality improvement project with carrier status for CF and SCH do not develop the actual
designed to assess and improve the quality of provider-parent disease, but their children may develop the disease if the other
communication after newborn screening (NBS) identifies het- parent is also a carrier. Unfortunately, many families of carrier
infants develop psychosocial complications after NBS, ranging from clinical levels of parental anxiety and depression to
• • •
impaired parent-child bonding and the vulnerable child synAuthor Affiliations: Center for Patient Care and Outcomes Research,
drome.5-10 NBS programs have developed materials for eduMedical College of Wisconsin (M Farrell, Christopher, La Pean, Eskra,
Collins); University of Wisconsin-Madison School of Nursing (Tluczek); cation and support of families, but first conversations can
State Laboratory of Hygiene, University of Wisconsin-Madison (Kennedy- be critical, and the quality of primary care providers’ (PCPs)
Parker, Hoffman); Department of Pediatrics, Medical College of Wisconsin communication about NBS has been criticized by parents and
(Panepinto); Departments of Pediatrics and Population Health, University
NBS officials.11,12 Psychosocial problems after carrier identificaof Wisconsin School of Medicine and Public Health (P Farrell).
tion are cited by bioethicists and others as grounds for delayCorresponding author: Michael H. Farrell, MD, Center for Patient Care ing or discontinuing some NBS activities.7-9,13,14 To ensure the
and Outcomes Research, Medical College of Wisconsin, 8701 Watertown
continuation of successful NBS programs and reduce harm
Plank Rd, Milwaukee, WI 53226; phone 414.955.8381; fax 414.955.6689;
from psychosocial complications, we developed the Wisconsin
e-mail mfarrell@mcw.edu.

ABSTRACT

Background: Newborn screening (NBS) enables early treatment, and some consider it a natu-
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Project on Improvement of Communication Process and
Outcomes after Newborn Screening (the Project). We adapted
our methods from quality improvement techniques used for
medical record review, simplified telephone follow-up, and
patient tracking, so that the Project would be affordable and
sustainable after research funding ended and replicable by other
NBS programs without major budget increases. Eventually, it
is hoped that these types of methods may be useful for other
genetic conditions, as well as for false-positive results of metabolic screening tests.
The purpose of this paper is to describe the initial workings of the Project, ranging from feasibility of identifying NBS
results and PCPs, to preliminary findings from evaluation surveys.

METHODS
At its core, the Project is designed to be a quality improvement effort by the NBS program of the Wisconsin State
Laboratory of Hygiene and the Department of Health Services,
with the Medical College of Wisconsin as a contracted agent.
Methods and materials are approved by Institutional Review
Boards at the Medical College of Wisconsin and University of
Wisconsin–Madison.
Setting
When NBS identifies either CF or SCH, the NBS laboratory
communicates by telephone with the infant’s PCP and subspecialists to facilitate identification, treatment, and follow-up.
The NBS laboratory obtains PCP contact information from
the birthing facility’s specimen collection card. Anecdotal experience shows that the clinician listed on the NBS card occasionally is incorrect, and the baby’s full name may not be listed
(eg, “Baby Boy Smith”). When the clinician’s name is not the
PCP, the listed clinician often is expected to forward the results
to the actual PCP or to take temporary responsibility for the
infant. When the baby’s full name is incorrect, the clinician or
the NBS laboratory must backtrack to the birthing facility to
connect the result with the correct infant and PCP.
Usual practice is somewhat different when NBS identifies
heterozygous carrier status for CF and SCH, which occurs in
far greater numbers than results indicating true CF or SCH.
SCH carrier results (defined by the presence of fetal, adult,
and sickle hemoglobin, or “FAS”) are mailed to the PCP
because these results are not medically urgent. Note that
NBS also identifies carriers for other hemoglobinopathies (eg,
Hemoglobin C, D, and E), but the Project is limited to hemoglobin S to focus its analyses on the most common condition.
CF carrier status in NBS is defined by a blood spot showing an elevated immunoreactive trypsinogen and a single
CF-associated mutation, followed by a normal sweat chloride
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test. The most common CF-associated mutation is ΔF508 but
there are many others.2 The sweat test is done because up to
2% to 5% of infants with a single mutation have an unmeasured second mutation that results in actual CF.2 It has been
recommended to have the sweat test before 8 weeks of age to
have the benefit of early identification,4 so the NBS laboratory
faxes results to PCPs and tracks whether sweat tests have been
done. The Project uses the term “likely CF carrier” for infants
who had an elevated immunoreactive trypsinogen and a single
CF-associated mutation, but who have not yet had a sweat
chloride test.
Project Design
The Project expands the standard NBS methods for telephone
follow-up to serve the typical number of about 900 infants
born each year in Wisconsin with SCH carrier status or likely
CF carrier status (Figure 1). An initial telephone call is conducted with the infant’s PCP immediately after the abnormal NBS result is found. A second call is conducted with the
infant’s parents when the infant is between 3 and 5 months
old, allowing sufficient time for infants to have at least 1 wellchild visit during which the NBS result could be discussed.
Scripts for telephone calls are similar to those that might be
used for purely clinical follow-up, but have some additional
research questions embedded in them. After telephone calls
to the PCP and parent, an anonymous evaluation survey is
distributed. The survey’s questions are described in the Results
section.
Participants
The main participants in the Project are the infants’ parents,
although data also are collected about the infants and their
PCPs.
To reduce confounding effects of other factors that might
cause potential anxiety or correlate with other psychosocial
issues, we exclude infants when the NBS report (1) lists more
than 1 abnormality, (2) states that the gestational age was <35
weeks, or (3) states that the calendar age at the time of specimen collection was >180 days of age. We also exclude infants if
we discover the infant required either (1) >5 days in a neonatal
intensive care unit, (2) hospitalization after discharge from the
nursery, or (3) evaluation for some other medical abnormality.
During the PCP call, we ask the PCP to identify parents who
do not speak English and other contraindications to contacting the family by asking, “Can you think of any reason why
it would not be appropriate to contact this family later this
year?”
Prior to the parent call, a second exclusion criterion is
implemented when we use NBS laboratory tracking data to
exclude parents of infants who had non-normal sweat test
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results (ie, results indicating the presence of CF).
Parents are offered a $20 gift certificate
to more than 200 local or Internet merchants as a gratuity for their participation.

Usual practice

Project methods

NBS result abnormal (SCH carrier, or likely CF carrier status)

Procedures
NBS lab sends result to the PCP
NBS lab sends result to the Project team
Protocol for locating PCPs. The Project’s
first goal is to ensure that the NBS laboratory report has reached the provider
PCP receives NBS result
who has actual primary care responsibilCall #1. Project team contacts PCP
ity for the infant. We begin by sending
(ideally before the PCP informs parent)
an introductory fax and a copy of the
PCP informs parent about the resulta
NBS result to the clinician listed by the
birthing facility, using information from
a directory maintained by the NBS laboratory. A Project caller then telephones
Over time, parents may…
Call #2. Project team contacts parent
 Access other sources of information
(infant is between 2 and 5 mo. old)
the clinician’s office and asks if the cli Confuse or forget what they learn
 Develop psychosocial problems
nician is the infant’s PCP. If the clinician does not know the infant or denies
a PCP relationship, the Project caller
attempts to find the PCP by asking the
Figure 1. Usual practice (left) and Project methods (right) after newborn screening identifies carrier
clinician for advice, and then by contactstatus for sickle cell hemoglobinopathy or likely carrier status for cystic fibrosis.
ing the birthing facility or its medical
Abbreviations = NBS, newborn screening; SCH, sickle cell hemoglobinopathy; CF, cystic fibrosis; PCP,
record department. If these methods are
the infant’s primary care provider.
aNot shown: for infants with the likely CF carrier result, the PCP orders a sweat chloride test to
not successful in finding the PCP, in a
verify that CF is not present.
few days the Project team contacts the
listed clinician again to see if the infant’s
parents have made an appointment. IRB
Approximately 10 days after the initial contact letter is
stipulations disallow the Project team from contacting families
directly.
mailed, a Project caller telephones the parents. Parents are asked
When the Project caller reaches the PCP, he or she asks if if they recall the letter and if they are willing to complete the
the PCP has questions about the NBS result or its implications, call. They are given the opportunity to discontinue the phone
and describes the Project goals and the parent call. If time call if it is an inconvenient time or if they simply are not interallows, the Project caller invites the PCP to rehearse how he or ested. The Project caller follows a carefully designed script that
she will inform the infant’s parent(s) about the result. Project weaves together components of informed consent, discussion
callers exercise judgment in deferring the rehearsal invitation if
about the screening result, open-ended survey questions, and
the PCP is hurried due to being contacted between patients.
fixed answer questions from established scales to assess psychoWhen the PCP does agree to rehearse, that portion of the call
social outcomes such as parental anxiety and perceptions of the
is audiotaped, transcribed, and de-identified for future analysis.
child’s health.15-18
Protocol for locating parents. If neither the NBS laboratory
Project callers have a clinical background, so they have the
report nor the PCP identify a reason for exclusion, the parents
are mailed an initial contact letter when the infant is about 3 expertise to perceive emotional distress or confusion over the
months old. The letter purposely does not mention the infant’s phone. If serious distress or confusion becomes evident, the
NBS result, in order to avoid confusion or distress for par- Project caller has the option of bypassing the research quesents who have not heard their child’s results or may not fully tions, transitioning to a purely clinical intervention. Regardless
understand the implications of the results. Also included is a of whether a parent completes the entire call, the conversation
“decline of contact” card to give the parents an opportunity to ends with a debriefing effort to ensure there is no lingering
decline participation without becoming fully informed about confusion, and to provide assistance with self-referral to addithe Project.
tional resources.
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Analysis
Both the PCP and parent calls are audio-recorded, transcribed,
de-identified, and abstracted for quantitative data. Descriptive
data, including the majority of data for this paper, are stored
in a Microsoft Access database (Redmond, Washington) and
analyzed using JMP software (SAS Institute, Cary, North
Carolina). A separate series of papers will report analysis of psychosocial data from the parent calls and communication data
from the PCP calls following our communication quality indicator approach. The communication quality indicators follow
our previously published techniques for jargon usage,19,20 assessments of understanding,21 organizing behaviors,22 communication about potential emotions,23 and inclusion of key content
messages.24,25

RESULTS
During the Project’s first 14 months, the Project team received
929 NBS results from the NBS laboratory; 709 showed SCH
carrier status and 220 showed likely CF carrier status. In 141 of
the 220 likely CF carrier results, the ∆F508 mutation was seen
(64.1%), while the other 79 infants had 1 of 18 other mutations from the 23 included on Wisconsin’s screening panel.
Gender was evenly distributed (49.1% male).
Information included on the NBS laboratory report, gestation age and the presence of multiple conditions, was sufficient
to exclude 112 infants (12.1%) without the need for a PCP call.
The remaining 817 infants who constitute the main sample for
this analysis were submitted by 70 different birthing facilities
and 4 home births. The median number of results listed for a
facility was 36 (SD 26.1). The facilities listed a total of 414 clinicians for their infants. The highest number of infants logged
for a single PCP was 13.
Information about PCPs
Accuracy of PCP listing provided by the birthing facility.
For 58.8% of infants, the birthing facility listed the accurate
PCP, and the NBS laboratory had accurate contact information
(Figure 2). For 14.2% of infants, the birthing facility had
listed a clinical partner of the correct PCP, so the NBS laboratory’s contact information was accurate even if the responsible
PCP had not been listed. For the other 27% of infants, the
information provided by the birthing facility was not sufficient
for the NBS result to automatically reach the PCP. For 20.9%
of the 817 infants, we found the PCP by following the protocol
described in the Methods section. For 7.3% of the 817 infants,
the birthing facility had provided the correct PCPs name, but
the PCP had changed locations recently enough that the NBS
report was faxed or mailed to an old address. PCPs of infants
with likely CF carrier results were more likely to have moved
than PCPs of infants with SCH carrier status (χ2, P = 0.03).
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We were unable to identify a PCP for 50 infants with SCH
carrier reports (6.1% of 817). In summary, using our contact
procedures, we were able to identify PCPs for 767 infants, or
93.9% of the 817 infants without exclusion criteria.
PCPs’ description of results communication. Of the 767
infants for whom we identified and reached a PCP during the
Project’s first 14 months, in 41 cases (5.4%) the PCP reported
that he or she had not received the NBS result fax. For the
other 672 infants, 130 PCPs reported already informing the
parent in person (19.4%), 134 had already told the parent via
telephone or planned to do so that day (19.9%), 377 planned
to tell the parent at the next scheduled appointment (56.1%),
3 planned to send a letter or an e-mail to the parent(s), and 16
PCPs had not decided how to inform the parent. Only 3 PCPs
planned to schedule a special appointment to discuss the NBS
result.
PCPs were more likely to wait until the next appointment
if the infant had an SCH carrier result than a likely CF carrier
result (73% vs 43%, χ2, P < 0.001).
When we asked PCPs if they had questions about the NBS
result or its implications, PCPs for 33 infants (4.9% of the 672)
asked for an explanation. PCPs were more likely to request an
explanation about likely CF carrier results than SCH carrier
results (13.3% vs 3.0%, χ2, P < 0.001).
Many PCPs were willing to rehearse telling the infant’s
parent(s). Of the 414 individual PCPs identified, we invited
rehearsals from 196 PCPs (47.3%) who had not yet informed
the parent(s). Of these, 118 agreed to rehearse (60.2%). Another
42 PCPs (21.4%) indicated willingness to rehearse for another
infant but deferred rehearsal for the current infant because of
time limitations. There were no significant differences by PCP
gender or clinical specialty with regard to availability for invitation or agreement to rehearse.
The PCPs who rehearsed supplied some demographic information. The average number of years since graduation from
training was 16.7 (SD 10.4 years), with a maximum of 44 years.
The average number of months since the PCP last discussed
genetic carrier status with a patient was 12.8 (SD 24.7 months).
Project Acceptability by PCPs. By the end of the 14-month
period analyzed for this paper, we received 79 anonymous
evaluations from PCPs who rehearsed with us. We asked,
“Was the information you obtained during the telephone
call useful?” and gave them 3 options: “very useful” (27/79
respondents), “somewhat useful” (44/79 respondents), and
“not at all useful” (8/74 respondents). We asked: “Was the
amount of time spent on the interview appropriate?” and gave
them 3 options: “just right” (71/79 respondents), “too long,”
(6/79 respondents), and “too short,” (0/79 respondents). Two
left the response choices blank. As shown in Table 1, slightly
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more than half of the PCPs reported that
being notified about the NBS result or
having the opportunity to rehearse had
influenced their interaction with parents.
Parent Information
Of the 767 infants for whom we identified and reached a PCP, we were told
of contraindications to us contacting the
parents for a follow-up call in 54 cases
(7%), including 29 infants whose families did not speak English. Seventeen
were excluded due to non-normal sweat
test before the parent call.
The outcomes of our attempts to
reach the remaining 696 infants with
SCH carrier results and likely CF carrier
results are listed in Table 2. Overall, we
Figure 2. Accuracy of PCP information provided by the birthing facility for SCH (sickle cell hemowere able to complete a call for 297 parglobinopathy) and CF (cystic fibrosis) carrier infants
ents, or 50.4% of eligible parents. The
infants’ average age at the time of the
call was 107.5 days old.
evaluate PCP explanations unfavorably if their health literacy
Most of the called parents were mothers, but 8 fathers was marginal or inadequate (χ2, P = 0.04).
(2.7%) were called. The average age of parents called was
26.7 years (SD 6.6). The youngest person we called was a Acceptability of the Project for the parents. By the end
14-year-old mother; the oldest was a 46-year-old mother. We of the 14-month period, we received 70 anonymous parent
asked most parents their ethnic background in an open-ended evaluations. When asked: “Was the information you obtained
question; 54% reported African American, 37% Caucasian, during the telephone call useful?”, 50 replied “very useful”
4% Latino, and 5% reported a combination, such as African (71.4%) and 17 replied “somewhat useful” (24.3%). Three
respondents said the information was “not at all useful”
American and Latino.
Results of the 3-item health literacy screener identified (4.3%). When asked: “Was the amount of time spent on the
25 parents with the potential for a significant limitation in interview appropriate?”, 63 said that the time was “just right”
health literacy (9%). Another 83 parents (29.9%) answered (90%), and 7 said it was “too long” (10%). No one responded
the screening questions with intermediate-range answers con- that the call was “too short.”
sistent with occasional health literacy problems.
Time and Labor Involved
Parents’ description of communication with the PCPs.
The parents of 38.5% of the SCH carrier infants did not recall
an explanation from the PCP. All of the parents of likely CF
carrier infants recalled an explanation except for one, despite
that infant having gone through the sweat testing process,
which includes meeting with a genetic counselor, prior to our
phone call.
When asked how well the PCP had explained the result,
48.5% of parents responded “well” or “very well.” Responses
were similar to a question about general satisfaction with the
NBS experience. Parents were more likely to be satisfied if
they remembered an explanation or if they evaluated the PCP’s
explanation favorably (χ2, P < 0.01). There was no apparent difference in satisfaction of parents of likely CF carrier infants
versus SCH carrier infants, but parents were more likely to

One of our main research questions at this point was the
amount of time and labor needed to do follow-up on communication processes and psychosocial outcomes in a typical
sample of nearly 900 families per year.
To facilitate planning for similar programs in the future, we
tracked time and expenses for clinical and research aspects of
the Project. Not counting IRB-required activities necessary for
research, we estimate that telephone calls to PCPs and related
administrative needs occupied half of each weekday for 1 staff
person, or about 20 hours per week. Parent calls take longer,
requiring almost 40 hours per week of staff time for calls and
documentation. Because of the research and IRB needs for the
Project, the call workload was spread out over several members
of our lab’s team, including a genetic counselor, 3 nurses, a
coordinator, and the project director (a pediatrician).
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Table 1. PCPs’ Opinions about the Influence of Being Called by the Project Team
“Yes”
n (%)

Opinion

“Somewhat”
n (%)

“No”
n (%)

29 (37.2)
30 (39)

35 (44.9)
35 (45.5)

23 (31.1)
27 (37)

38 (51.4)
35 (47.9)

“Being notified about the result influenced my interaction with…
… this parent.”
… all parents.”

14 (17.9)
12 (15.6)

“The rehearsal session influenced my interaction with…
… this parent.”
… all parents.”

13 (17.6)
11 (15.1)

Table 2. Recruiting Experience with Parents
Parents of infants with NBS results showing…
SCH carrier status
Likely CF carrier status
Outcome of parent recruiting effort
Unable to find reliable contact information
No response to voicemails
Parent reached by telephone but declined
Parent called
Total number of eligible infants

n (% for result)

n (% for result)

102 (19.0%)
183 (34.1%)
45 (8.4%)
206 (37.4%)
536

5 (3.1%)
46 (28.8%)
18 (11.3%)
91 (56.9%)
160

Limitations
The Project methods are elaborate in
order to integrate into usual-practice
NBS, but some limitations are inevitable.
Some selection bias may be present despite
our response rate and status as a quality
improvement project. Due to IRB restrictions and NBS legislative rules about contacting parents directly, we have little or
no reliable data about many of the parents
who were not reachable via the 2 protocols described earlier. In addition, the use
of survey methods may be associated with
the social desirability and Hawthorne
effects, a change in participant behavior
due to a sense of observation. Further
study may be needed to know whether
it is reasonable to generalize our findings
about infants with carrier status for CF
and SCH to other types of carrier states
and to false positive NBS results.

DISCUSSION

CONCLUSION

Decades of experience have shown that NBS effectively can
identify diseases before they become symptomatic, but also that
NBS can be followed by serious psychosocial complications.5-10
These complications and other communication problems are
found across entire states, so we have developed a populationscale, quality improvement approach to addressing them.
We were pleased at the generally favorable reactions to our
calls by PCPs and parents. Some of the busiest PCPs were
annoyed to be telephoned directly, but our evaluation data and
PCP calls indicated that most PCPs either were grateful or neutral. To improve acceptability for PCPs with large numbers of
infants, we developed a protocol for relaying communications
through office staff or fax machines. We were impressed by
the number of PCPs who were willing to rehearse with us. We
hope eventually expand to our service to parents who require
English-language translation.
Our most troubling experience has been difficulty locating
physicians willing to assume clinical responsibility for some
carrier infants. This difficulty stands in sharp contrast to the
urgency with which subspecialists and PCPs take action when
presented with NBS reports for a life-threatening illness. For
NBS to result in more good than harm, some of that urgency
needs to be extended to parents of carrier infants. A casual attitude to carrier results may be partially to blame for the psychosocial complications seen in many previous studies.

To ensure that NBS and associated interventions consistently
lead to more good than harm, clinicians need to assume
responsibility and provide high-quality care for carrier and disease-affected infants. Future reports will comment on the psychosocial data we have gathered which indicates that parents
do experience real psychosocial effects of poor communication
about NBS results. The role of communication quality assurance and centralized follow-up will be to support PCPs and
parents as they deal with positive and false-alarm NBS results.
We further hope that the Project and forthcoming papers will
serve as models for other population-scale efforts to improve
the quality of communication in many other areas of health
care.
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